Real-world efficacy of tucatinib in Danish human epidermal growth factor receptor 2-positive metastatic breast cancer
{{output}}
Introduction: Tucatinib in combination with trastuzumab and capecitabine is approved for the treatment of metastatic human epidermal growth factor receptor 2 (HER2) positive breast cancer in third-line and later based on the resu... ...
